Genes required for free phage production are essential for pseudomonas aeruginosa chronic lung infections

Journal of Infectious Diseases

Volumn 213, Issue 3, 2016, Pages 395-402

  Lemieux, Andrée Ann ^a   Jeukens, Julie ^a   Kukavica Ibrulj, Irena ^a   Fothergill, Joanne L ^b   Boyle, Brian ^a   Laroche, Jérôme ^a   Tucker, Nicholas P ^c   Winstanley, Craig ^b   Levesque, Roger C ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

bacteriophages; chronic infection; gene expression; Pseudomonas aeruginosa; respiratory health; virulence

Indexed keywords

TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; CONTROLLED STUDY; GENE EXPRESSION; GENE INSERTION; GENOMIC ISLAND; IN VIVO STUDY; LUNG INFECTION; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHAGE; PSEUDOMONAS INFECTION; QUANTITATIVE ANALYSIS; RAT; RNA SEQUENCE; ANIMAL; CHRONIC DISEASE; GENE EXPRESSION REGULATION; GENETICS; LUNG DISEASE; METABOLISM; MICROBIOLOGY; MUTATION; PHYSIOLOGY; PSEUDOMONAS PHAGE; VIRUS REPLICATION;

ANIMALS; CHRONIC DISEASE; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENOMIC ISLANDS; LUNG DISEASES; MUTATION; PROPHAGES; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PHAGES; RATS; TRANSCRIPTOME; VIRUS REPLICATION;

EID: 84959903102     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv415     Document Type: Article

References (35)

1. Stover CK, Pham XQ, Erwin AL,. et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 2000; 406: 959-64.
2. Cheng K, Smyth RL, Govan JR,. et al. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996; 348: 639-42.
3. Aaron SD, Vandemheen KL, Ramotar K,. et al. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA 2010; 304: 2145-53.
4. Jeukens J, Boyle B, Kukavica-Ibrulj I,. et al. Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients. PLoS One 2014; 9: e87611.
5. Dettman JR, Rodrigue N, Aaron SD, Kassen R. Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 2013; 110: 21065-70.
6. Winstanley C, Langille MG, Fothergill JL,. et al. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res 2009; 19: 12-23.
7. Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, Winstanley C. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol 2007; 7: 45.
8. Kukavica-Ibrulj I, Bragonzi A, Paroni M,. et al. In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. J Bacteriol 2008; 190: 2804-13.
9. Salunkhe P, Smart CH, Morgan JA,. et al. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 2005; 187: 4908-20.
10. Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 2004; 59: 334-6.
11. Ashish A, Shaw M, Winstanley C, Ledson MJ, Walshaw MJ. Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)-A cause for concern?. J Cyst Fibros 2012; 11: 173-9.
12. McCallum SJ, Gallagher MJ, Corkill JE, Hart CA, Ledson MJ, Walshaw MJ. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax 2002; 57: 559-60.
13. Fothergill JL, Mowat E, Walshaw MJ, Ledson MJ, James CE, Winstanley C. Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2011; 55: 426-8.
14. Cash HA, Woods DE, McCullough B, Johanson WG Jr, Bass JA. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis 1979; 119: 453-9.
15. Lehoux DE, Sanschagrin F, Levesque RC. Genomics of the 35-kb pvd locus and analysis of novel pvdIJK genes implicated in pyoverdine biosynthesis in Pseudomonas aeruginosa. FEMS Microbiol Lett 2000; 190: 141-6.
16. Lehoux DE, Sanschagrin F, Kukavica-Ibrulj I, Potvin E, Levesque RC. Identification of novel pathogenicity genes by PCR signature-tagged mutagenesis and related technologies. Methods Mol Biol 2004; 266: 289-304.
17. Winsor GL, Lam DK, Fleming L,. et al. Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 2011; 39: D596-600.
18. Brussow H, Canchaya C, Hardt WD. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 2004; 68: 560-602.
19. Tormo-Mas MA, Mir I, Shrestha A,. et al. Moonlighting bacteriophage proteins derepress staphylococcal pathogenicity islands. Nature 2010; 465: 779-82.
20. Brockhurst MA, Colegrave N, Rozen DE. Next-generation sequencing as a tool to study microbial evolution. Mol Ecol 2011; 20: 972-80.
21. Rice SA, Tan CH, Mikkelsen PJ,. et al. The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. ISME J 2009; 3: 271-82.
22. James CE, Fothergill JL, Kalwij H,. et al. Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa. BMC Microbiol 2012; 12: 216.
23. Chen Y, Golding I, Sawai S, Guo L, Cox EC. Population fitness and the regulation of Escherichia coli genes by bacterial viruses. PLoS Biol 2005; 3: e229.
24. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 1998; 30: 295-304.
25. Rashid MH, Rumbaugh K, Passador L,. et al. Polyphosphate kinase is essential for biofilm development, quorum sensing, and virulence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 2000; 97: 9636-41.
26. Frees D, Qazi SN, Hill PJ, Ingmer H. Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence. Mol Microbiol 2003; 48: 1565-78.
27. Laux DC, Corson JM, Givskov M,. et al. Lysophosphatidic acid inhibition of the accumulation of Pseudomonas aeruginosa PAO1 alginate, pyoverdin, elastase and LasA. Microbiology 2002; 148: 1709-23.
28. Schaber JA, Carty NL, McDonald NA,. et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. J Med Microbiol 2004; 53: 841-53.
29. Potvin E, Lehoux DE, Kukavica-Ibrulj I,. et al. In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol 2003; 5: 1294-308.
30. Smith EE, Buckley DG, Wu Z,. et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 2006; 103: 8487-92.
31. Folkesson A, Jelsbak L, Yang L,. et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol 2012; 10: 841-51.
32. Lehoux DE, Sanschagrin F, Levesque RC. Discovering essential and infection-related genes. Curr Opin Microbiol 2001; 4: 515-9.
33. Sanschagrin F, Kukavica-Ibrulj I, Levesque RC. Essential genes in the infection model of Pseudomonas aeruginosa PCR-based signature-tagged mutagenesis. Methods Mol Biol 2008; 416: 61-82.
34. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26: 139-40.
35. Klipper-Aurbach Y, Wasserman M, Braunspiegel-Weintrob N,. et al. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 1995; 45: 486-90.